Loading...

RCEL AVITA MEDICAL INC Investments/Divestments 8-K Filing

VT M

RCL

AVITA MEDICAL INC

(RCEL)

2024 8-K

Credit Agreement Update

Annual Meeting Results

Financial Results Announced

Management Changes

Financial Results Announced

Credit Agreement Update

Director Appointment

Credit Amendment Update

Management Change

Equity Placement

Equity Offerings

Management Changes

Rights Offerings

Financial Statements

Manufacturing Agreement

Credit Agreement Amendment

Financial Results Update

Earnings Reports

Distribution Agreement

Management Change

Annual Meeting of Stockholders

Financial Results Announcement

Earnings Updates

Financial Results Announcement

Distribution Agreement

Financial Results Announcement

Departure of Directors or C...

Credit Agreement

FDA Approval Update

Appointment of CFO

Annual Meeting Approval

Financial Results and Resig...

Appointment of Director

Amendment to Employment Agr...

Appointment of Directors

Conference Presentation

Webinar Briefing and Presen...

Management Changes

External Links:

AVITA Medical, Inc. has entered into an exclusive distribution agreement with Stedical Scientific to commercialize PermeaDerm Biosynthetic Wound Matrix in the United States.

AI Assistant

AVITA MEDICAL INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.